[go: up one dir, main page]

SE8703034L - Oralt terapeutiskt system med systemisk verkan - Google Patents

Oralt terapeutiskt system med systemisk verkan

Info

Publication number
SE8703034L
SE8703034L SE8703034A SE8703034A SE8703034L SE 8703034 L SE8703034 L SE 8703034L SE 8703034 A SE8703034 A SE 8703034A SE 8703034 A SE8703034 A SE 8703034A SE 8703034 L SE8703034 L SE 8703034L
Authority
SE
Sweden
Prior art keywords
therapeutic system
carbamazepine
water
core
drug
Prior art date
Application number
SE8703034A
Other languages
Unknown language ( )
English (en)
Other versions
SE502590C2 (sv
SE8703034D0 (sv
Inventor
S C Khanna
T Ruttimann
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE8703034D0 publication Critical patent/SE8703034D0/sv
Publication of SE8703034L publication Critical patent/SE8703034L/sv
Publication of SE502590C2 publication Critical patent/SE502590C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE8703034A 1986-08-07 1987-08-03 Oralt terapeutiskt system innehållande karbamazepin med systemisk verkan, förfarande för framställning och användning därav SE502590C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH3172/86A CH668187A5 (de) 1986-08-07 1986-08-07 Therapeutisches system mit systemischer wirkung.

Publications (3)

Publication Number Publication Date
SE8703034D0 SE8703034D0 (sv) 1987-08-03
SE8703034L true SE8703034L (sv) 1988-02-08
SE502590C2 SE502590C2 (sv) 1995-11-20

Family

ID=4250176

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8703034A SE502590C2 (sv) 1986-08-07 1987-08-03 Oralt terapeutiskt system innehållande karbamazepin med systemisk verkan, förfarande för framställning och användning därav

Country Status (30)

Country Link
US (1) US4857336A (sv)
JP (1) JP2592460B2 (sv)
KR (1) KR950006219B1 (sv)
AT (1) AT397344B (sv)
AU (1) AU597403B2 (sv)
BE (1) BE1000235A3 (sv)
CA (1) CA1302267C (sv)
CH (1) CH668187A5 (sv)
DD (1) DD285718A5 (sv)
DE (1) DE3725824C2 (sv)
DK (1) DK175497B1 (sv)
ES (1) ES2007100A6 (sv)
FI (1) FI86143C (sv)
FR (1) FR2602425B1 (sv)
GB (1) GB2193632B (sv)
GR (1) GR871234B (sv)
HK (1) HK33793A (sv)
HU (1) HU206978B (sv)
IE (1) IE59718B1 (sv)
IL (1) IL83386A (sv)
IT (1) IT1215618B (sv)
LU (1) LU86966A1 (sv)
MY (1) MY100767A (sv)
NL (1) NL194780C (sv)
NO (1) NO173726C (sv)
NZ (1) NZ221347A (sv)
PH (1) PH25090A (sv)
PT (1) PT85489B (sv)
SE (1) SE502590C2 (sv)
ZA (1) ZA875804B (sv)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3868077D1 (de) * 1987-01-14 1992-03-12 Ciba Geigy Ag Therapeutisches system fuer schwerloesliche wirkstoffe.
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
NZ226179A (en) * 1987-09-24 1991-04-26 Merck & Co Inc Controlled porosity osmotic pump for sustained release of pharmaceutical agents
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
AU657114B2 (en) * 1991-01-16 1995-03-02 Fmc Corporation Carrier for active agents, and solid dosage forms prepared therewith
US5326570A (en) * 1991-07-23 1994-07-05 Pharmavene, Inc. Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US20040191314A1 (en) * 1994-04-28 2004-09-30 Frank Jao Antiepileptic dosage form and process for protecting antiepileptic drug
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
US5980942A (en) * 1997-01-23 1999-11-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release matrix tablet formulations of carbamazepine
US6296873B1 (en) 1997-01-23 2001-10-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Zero-order sustained release delivery system for carbamazephine derivatives
US20020022056A1 (en) 1997-02-14 2002-02-21 Burkhard Schlutermann Oxacarbazepine film-coated tablets
CO4920215A1 (es) * 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
DE59804823D1 (de) 1997-09-25 2002-08-22 Bayer Ag Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
AU746339B2 (en) * 1998-04-29 2002-04-18 Arius Two, Inc. Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
US6706283B1 (en) * 1999-02-10 2004-03-16 Pfizer Inc Controlled release by extrusion of solid amorphous dispersions of drugs
MXPA03006217A (es) * 2001-01-12 2004-10-15 Sun Pharmaceutical Ind Ltd Sistema de administracion espaciada de farmacos.
IN190699B (sv) * 2001-02-02 2003-08-16 Sun Pharmaceutical Ind Ltd
MXPA03008997A (es) * 2001-04-10 2004-02-12 Sun Pharmaceutical Ind Ltd Composicion de liberacion por impulso temporizado.
RU2189225C1 (ru) * 2001-09-14 2002-09-20 Нестерук Владимир Викторович Лекарственное средство на основе карбамазепина
US20030175346A1 (en) * 2002-02-01 2003-09-18 Anne Billotte Osmotic delivery system
US20030161882A1 (en) * 2002-02-01 2003-08-28 Waterman Kenneth C. Osmotic delivery system
US6572889B1 (en) 2002-03-07 2003-06-03 Noveon Ip Holdings Corp. Controlled release solid dosage carbamazepine formulations
AU2003231919A1 (en) * 2002-03-14 2003-09-22 Sun Pharmaceutical Industries Limited Oral controlled drug delivery system containing carbamazepine
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
RU2240798C1 (ru) * 2003-06-25 2004-11-27 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция, обладающая противосудорожным и психотропным действием, и способ ее получения
EP1690540A1 (en) * 2005-02-15 2006-08-16 Neuro3D Composition comprising ocaperidone
BRPI0610257A2 (pt) * 2005-04-25 2010-06-08 Teva Pharma formulações de liberação prolongada
US20070071819A1 (en) * 2005-05-30 2007-03-29 Kesarwani Amit K Multiple unit modified release compositions of carbamazepine and process for their preparation
RS54764B1 (sr) 2006-07-21 2016-10-31 Biodelivery Sciences Int Inc Sredstvo za transmukozalnu isporuku sa povećanim nakupljanjem
US20090143362A1 (en) * 2007-12-04 2009-06-04 Barabde Umesh Vinayakrao Carbamazepine formulations
WO2009073215A1 (en) * 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
EP2240162A4 (en) 2007-12-06 2013-10-09 Bend Res Inc NANOTE PARTICLES WITH A NON-IONIZABLE POLYMER AND AN AMIN-FUNCTIONALIZED METHACRYLATE COPOLYMER
JP6158810B2 (ja) 2011-08-18 2017-07-05 バイオデリバリー サイエンシズ インターナショナル，インコーポレーテッド ブプレノルフィンの乱用抵抗性粘膜付着性送達デバイス
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4431641A (en) * 1980-10-17 1984-02-14 Ciba-Geigy Corporation Pharmaceutical compositions having antiepileptic and antineuralgic action
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
US4553973A (en) * 1982-07-12 1985-11-19 Alza Corporation Process for preparing osmotic device
GB2150830B (en) * 1983-12-05 1987-08-19 Alza Corp Drug dispenser
US4716031A (en) * 1984-03-21 1987-12-29 Alza Corporation Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug
US4685918A (en) * 1985-02-01 1987-08-11 Merck & Co., Inc. Lipid osmotic pump

Also Published As

Publication number Publication date
GB8717643D0 (en) 1987-09-03
IE59718B1 (en) 1994-03-23
GB2193632B (en) 1990-04-25
NO173726C (no) 1994-01-26
AU7661787A (en) 1988-02-11
NO873298D0 (no) 1987-08-06
AU597403B2 (en) 1990-05-31
ATA199387A (de) 1993-08-15
IT8748270A0 (it) 1987-08-05
DK410787D0 (da) 1987-08-06
FI873409A0 (fi) 1987-08-05
HU206978B (en) 1993-03-01
FI86143C (sv) 1992-07-27
NO873298L (no) 1988-02-08
DK410787A (da) 1988-02-08
AT397344B (de) 1994-03-25
KR880002511A (ko) 1988-05-09
IE872110L (en) 1988-02-07
FI86143B (fi) 1992-04-15
IL83386A (en) 1992-01-15
NL8701857A (nl) 1988-03-01
IT1215618B (it) 1990-02-22
US4857336A (en) 1989-08-15
JPS6344525A (ja) 1988-02-25
MY100767A (en) 1991-02-14
JP2592460B2 (ja) 1997-03-19
GR871234B (en) 1987-12-08
FR2602425B1 (fr) 1990-09-14
PH25090A (en) 1991-02-19
NL194780C (nl) 2003-03-04
DE3725824A1 (de) 1988-02-11
SE502590C2 (sv) 1995-11-20
PT85489A (en) 1987-09-01
LU86966A1 (fr) 1989-03-08
DD285718A5 (de) 1991-01-03
NO173726B (no) 1993-10-18
CA1302267C (en) 1992-06-02
FR2602425A1 (fr) 1988-02-12
DE3725824C2 (de) 1998-12-17
NL194780B (nl) 2002-11-01
BE1000235A3 (fr) 1988-09-20
SE8703034D0 (sv) 1987-08-03
NZ221347A (en) 1989-12-21
HK33793A (en) 1993-04-16
PT85489B (pt) 1990-06-29
ZA875804B (en) 1988-02-08
ES2007100A6 (es) 1989-06-01
CH668187A5 (de) 1988-12-15
IL83386A0 (en) 1987-12-31
HUT44930A (en) 1988-05-30
DK175497B1 (da) 2004-11-15
FI873409A7 (fi) 1988-02-08
KR950006219B1 (ko) 1995-06-12
GB2193632A (en) 1988-02-17

Similar Documents

Publication Publication Date Title
SE8703034D0 (sv) Oralt terapeutiskt system med systemisk verkan
FI884280A0 (sv) Förfarande för framställning av en belagd doseringsform med fördröjd frigivning
DE69225135D1 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
ES2051881T3 (es) Procedimiento de preparacion de un formulacion farmaceutica de liberacion prolongada.
ATE19589T1 (de) Pharmazeutische dreilagen-filmpraeparate mit lang anhaltender wirkung.
ES2117642T3 (es) Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
ES2171469T3 (es) Composicion administrada por via nasal y preparacion que la contiene.
FI940787A0 (sv) Doseringsform för att dosera läkemedel under en kort tidsperiod
FI922325A0 (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
ATE87471T1 (de) Eine fluessige verabreichungsform fuer orale verabreichung einer pharmazeutischen substanz.
JPS5636413A (en) Medicinal percutaneous release system
NO884947L (no) Fremgangsmaate for fremstilling av farmasoeytisk doseringsform med kontrollert frigjoerelse.
SE9301057L (sv) Beredning med kontrollerad frisättning
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
DE3770937D1 (de) Tablette zur pharmazeutischen anwendung sukzessiver freisetzung.
TR199500832A2 (tr) Benzimidazol türevleri ve bunlarin medikal terapide kullanimi ve bunlari iceren farmasötik formülasyonlar.
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
MX9203556A (es) Una forma de dosificacion para administrar los farmacos beneficos pseudoefedrina y bromofeniramina.
NO890186L (no) Fremgangsmaate for fremstilling av en avgivelses- og/ellerdoseringsform for legemiddelaktive stoffer.
NO912416D0 (no) Terapeutisk aktiv benzimidazolforbindelse og fremgangsmaate for dens fremstilling.
DE69922017D1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
ES2119748T3 (es) Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.
DE50000864D1 (de) Verwendung von desoxypeganin zur behandlung von drogenabhängigkeit
DE59910944D1 (de) Transdermales therapeutisches system zur anwendung von candesartan

Legal Events

Date Code Title Description
NUG Patent has lapsed